Back to search
FDAFDA · Food and drugs·Recall number Z-1037-2017

AFX Endovascular AAA System, Endoleak Type IIIA Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (AAA).

Published January 25, 2017 · Recall initiated: December 27, 2016

Summary

FDA records medical device Class II recall Z-1037-2017, published January 25, 2017 and initiated December 27, 2016. Recalling firm: Endologix; Status: Terminated; Lot: The correction is not lot specific. It applies to AFX procedures conducted after July 2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System (AFX System).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Endologix
Distributor
Worldwide Distribution - US (nationwide) and Internationally to Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Israel, Italy, Latvia, Luxembourg, Monaco, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland, Turkey, and United Kingdom.
Lot
The correction is not lot specific. It applies to AFX procedures conducted after July 2015
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was AFX Endovascular AAA System, Endoleak Type IIIA Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (AAA). recalled?

Yes. FDA published recall Z-1037-2017 on January 25, 2017. Reported hazard: Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System (AFX System).

What should I do if I have this product?

Voluntary: Firm initiated · Letter